Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04254133

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Genetic Information to Inform Treatment and Screening (GIFTS) Study for Prostate Cancer

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,360 (estimated)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
Male
Age
35 Years – 89 Years
Healthy volunteers
Accepted

Summary

This trial studies the role of inherited (present at birth) mutations in cancer risk genes such as BRCA2, BRCA1, ATM, CHEK2, and others in relation to prostate cancer. This study may help researchers understand the frequency and importance of inherited mutations in cancer risk genes in patients with prostate cancer and potentially help identify better ways to treat cancer in patients who have a mutation in one of these genes.

Detailed description

OUTLINE: Participants complete questionnaire over 20 minutes at baseline, then undergo collection of saliva sample for genetic testing. Participants identified to have an inherited mutation in a deoxyribonucleic acid (DNA) repair gene undergo genetic counseling. Participants whose genetic testing does not indicate an inherited mutation in a DNA repair gene receive a letter thanking them for their participation and emphasizing the importance of ongoing communication with their physician and family members about cancer risk. Participants may also receive an educational flyer with or without a educational video regarding prostate cancer and genetic testing. Participants will be sent newsletters every year to encourage study engagement and update health questionnaires every two years.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnaireComplete questionnaire
PROCEDUREBiospecimen CollectionProvide saliva samples
DIAGNOSTIC_TESTGenetic TestingUndergo genetic testing
OTHERGenetic CounselingUndergo counseling
OTHERLaboratory Biomarker AnalysisCorrelative Studies

Timeline

Start date
2018-11-30
Primary completion
2028-08-31
Completion
2028-08-31
First posted
2020-02-05
Last updated
2026-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04254133. Inclusion in this directory is not an endorsement.